| Dr Lynn L Woo, MD | |
|
11100 Euclid Ave, Rbc Suite 2311, Cleveland, OH 44106-1716 | |
| (216) 844-8440 | |
| (216) 844-8179 |
| Full Name | Dr Lynn L Woo |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Experience | 22 Years |
| Location | 11100 Euclid Ave, Cleveland, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710151386 | NPI | - | NPPES |
| 560128 | Other | OH | WELLCARE |
| 3067050 | Medicaid | OH | |
| P00987689 | Other | OH | RAILROAD MEDICARE |
| 1710151386 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 57.005557 (Ohio) | Secondary |
| 2088P0231X | Urology - Pediatric Urology | 095546 (Ohio) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
| University Hospitals Medical Group Inc | 4789682493 | 1466 |
News Archive
The University of Illinois at Chicago has received a five-year, $4.3 million grant from the National Institute on Disability and Rehabilitation Research and the Administration for Community Living to establish a new, multi-institutional center to study the needs of families caring for people with disabilities.
Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. However, a study in the October Journal of Lipid Research finds that similar statin drugs can have profoundly different effects on brain cells -both beneficial and detrimental.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.
A neuropeptide hormone called orexin-A—which plays an important role in regulating the normal sleep-wake cycle—also affects emergence (waking up) after anesthesia, reports an experimental study in the October issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
› Verified 4 days ago
| Entity Name | The Cleveland Clinic Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679525919 PECOS PAC ID: 1850203555 Enrollment ID: O20031103000049 |
News Archive
The University of Illinois at Chicago has received a five-year, $4.3 million grant from the National Institute on Disability and Rehabilitation Research and the Administration for Community Living to establish a new, multi-institutional center to study the needs of families caring for people with disabilities.
Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. However, a study in the October Journal of Lipid Research finds that similar statin drugs can have profoundly different effects on brain cells -both beneficial and detrimental.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.
A neuropeptide hormone called orexin-A—which plays an important role in regulating the normal sleep-wake cycle—also affects emergence (waking up) after anesthesia, reports an experimental study in the October issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
› Verified 4 days ago
| Entity Name | The Metrohealth System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053353896 PECOS PAC ID: 8628982949 Enrollment ID: O20031119000355 |
News Archive
The University of Illinois at Chicago has received a five-year, $4.3 million grant from the National Institute on Disability and Rehabilitation Research and the Administration for Community Living to establish a new, multi-institutional center to study the needs of families caring for people with disabilities.
Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. However, a study in the October Journal of Lipid Research finds that similar statin drugs can have profoundly different effects on brain cells -both beneficial and detrimental.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.
A neuropeptide hormone called orexin-A—which plays an important role in regulating the normal sleep-wake cycle—also affects emergence (waking up) after anesthesia, reports an experimental study in the October issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
› Verified 4 days ago
| Entity Name | University Hospitals Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669499414 PECOS PAC ID: 4789682493 Enrollment ID: O20061113000301 |
News Archive
The University of Illinois at Chicago has received a five-year, $4.3 million grant from the National Institute on Disability and Rehabilitation Research and the Administration for Community Living to establish a new, multi-institutional center to study the needs of families caring for people with disabilities.
Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. However, a study in the October Journal of Lipid Research finds that similar statin drugs can have profoundly different effects on brain cells -both beneficial and detrimental.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.
A neuropeptide hormone called orexin-A—which plays an important role in regulating the normal sleep-wake cycle—also affects emergence (waking up) after anesthesia, reports an experimental study in the October issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lynn L Woo, MD 24701 Euclid Ave, 3rd Floor, Euclid, OH 44117-1714 Ph: () - | Dr Lynn L Woo, MD 11100 Euclid Ave, Rbc Suite 2311, Cleveland, OH 44106-1716 Ph: (216) 844-8440 |
News Archive
The University of Illinois at Chicago has received a five-year, $4.3 million grant from the National Institute on Disability and Rehabilitation Research and the Administration for Community Living to establish a new, multi-institutional center to study the needs of families caring for people with disabilities.
Besides their tremendous value in treating high cholesterol and lowering the risk of heart disease, statins have also been reported to potentially lower the risks of other diseases, such as dementia. However, a study in the October Journal of Lipid Research finds that similar statin drugs can have profoundly different effects on brain cells -both beneficial and detrimental.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for treatment resistant depression therapy, AstraZeneca/Targacept's TC-5214 will earn Decision Resources' proprietary clinical gold standard status in 2013 (following its approval that year) and through 2018.
A neuropeptide hormone called orexin-A—which plays an important role in regulating the normal sleep-wake cycle—also affects emergence (waking up) after anesthesia, reports an experimental study in the October issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
› Verified 4 days ago
Andrew Wood, Urology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 616-706-9286 | |
Dr. Michael T Berte, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 6900 Pearl Rd, 2nd Floor, Cleveland, OH 44130 Phone: 440-845-0900 Fax: 440-845-7355 | |
William E Forsythe Iii, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 800-223-2273 | |
Dr. Irina Jaeger, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 216-844-3009 | |
Rajan Ramanathan, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave, Cleveland, OH 44195 Phone: 216-444-2000 | |
Dr. Jason Thomas Jankowski, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 11100 Euclid Ave, Cleveland, OH 44106 Phone: 440-617-4726 | |
Petar Bajic, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 9500 Euclid Ave # Q10-1, Cleveland, OH 44195 Phone: 216-444-1231 |